Press Releases

For media inquiries,
please contact:
Keri Mattox
Pure Communications Inc.
215.791.0105

2013

May 7, 2013
CytomX Therapeutics Named a Finalist for the 2013 Red Herring Top 100 North America Award

April 3, 2013
New Data Highlighting CytomX's Probody Platform and EGFR Probody Drug Conjugate to be Presented at the AACR Annual Meeting 2013

2012

July 31, 2012
CytomX Therapeutics Expands Series B Financing; Canaan Partners Joins Syndicate

March 6, 2012
CytomX Therapeutics Appoints Hoyoung Huh, M.D., Ph.D., Chairman of Board of Directors

2011

October 6, 2011
CytomX Therapeutics Promotes Henry Lowman, Ph.D., to Chief Scientific Officer

August 11, 2011
CytomX Announces Appointment of Sean McCarthy as Chief Executive Officer

January 5, 2011
CytomX Therapeutics Appoints Sean McCarthy as Chief Business Officer

2010

November 19, 2010
CytomX Therapeutics Announces Key R&D Leadership Appointments; Mark Rolfe, Ph.D., Named Chief Scientific Officer and Henry Lowman, Ph.D., Named Vice President of Research

November 12, 2010
CytomX Therapeutics Awarded Two Federal Research Grants under the Qualifying Therapeutic Discovery Project (QTDP) Program

September 23, 2010
CytomX Therapeutics Completes $30 Million Series B Financing